Asset Management Ventures, a venture capital firm, led a $35m Series B round in SubjectWell, an engagement platform for matching patients with chronic health conditions, with participation from Bertelsmann. “Patient recruitment remains the largest choke point in clinical development – despite over $5bn being spent annually. SubjectWell’s highly differentiated and scalable solution markedly reduces our clients’ enrollment timelines. SubjectWell expands access to clinical trials by engaging the 96 percent of the population that has never participated in clinical research – this approach allows us to engage a much more diverse patient population as we register 250,000 new patients per month,” Ivor Clarke, SubjectWell CEO.